NICE Recommends Genedrive Test in Draft Guidance to Prevent Hearing Loss in Newborns
NICE recommended that Genedrive's MT-RNR1 ID Kit should be adopted by the NHS for the prevention of antibiotic-induced hearing loss.
UK's NICE to Accelerate Assessment of Genedrive Test
NICE plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via a new program.
The assay and point-of-care device were implemented in a trial in cooperation with clinical partners based at Manchester University NHS Foundation Trust.
Genedrive Rapid Molecular COVID-19 Test Receives CE Mark
The point-of-care test uses RT-LAMP technology and returns positive results in eight minutes and negative results in 17 minutes.
Genedrive Receives CE Mark for Next-Generation Gene Amplification Platform
The system was developed to support the commercial launch of Genedrive's MT-RNR1 test for antibiotic-induced hearing loss in newborns.
May 22, 2020
Genedrive Receives CE Mark for SARS-CoV-2 PCR Kit
Nov 21, 2019
Genedrive Receives CE Mark for Hearing Loss Assay
Aug 23, 2019
Jun 19, 2018